We propose that aberrant up-regulation of the pioneer factor FOXA1 recommissions both SRR124 and SRR134 in tumor cells, driving SOX2 overexpression in breast and lung adenocarcinoma. This evidence concerns the gene SOX2 and lung adenocarcinoma.